CD8+Trm cells in the CRC have significant resident properties and tumor reactivity. With a unique methylome pattern and distinct epigenetic properties, they can enhance tissue immunity, improve barrier function, and prevent microbiota-associated diseases. This evidence concerns the gene CD8A and neoplasm.